发明名称 HUMAN MONOCLONAL ANTIBODY HAVING FAT-REDUCING EFFECT
摘要 <p>Purified polypeptides (I) are new. They have an amino acid (aa) sequence practically identical with sequences (1; 96 aa) and/or (3; 110 aa), reproduced, and bind to low density lipoprotein (LDL), especially LDL-cholesterol, and/or their oxidized forms. Independent claims are also included for the following: (1) purified polypeptides that include sequences (1) and/or (3); (2) complementarity determining regions (CDR), or their functional fragments, of (1) and/or (3); and (3) method for generating antibodies (Ab) by the hybridoma technique in which hybridomas are prepared from the heteromyeloma cell line HAB-1, or its subclones, and B lymphocytes from human spleen, lymph nodes or blood. ACTIVITY : Antilipemic; Nephrotropic; Antiarteriosclerotic; Cardiant. Purified SAM-6.10 antibody (containing (1) and (3) as its variable regions) was injected (1 mg) intraperitoneally into mice, then the LDL content in the serum determined. The contents were 14 and 12 mg/dl after 24 and 48 hours, respectively; contrast 18 and 17 for an animal injected with 1 mg of an isotype control antibody. MECHANISM OF ACTION : Binding to (oxidized) low density lipoprotein, so functioning in a manner analogous to the known scavenger pathway.</p>
申请公布号 EP1682580(B1) 申请公布日期 2013.05.15
申请号 EP20040802719 申请日期 2004.11.12
申请人 PATRYS LIMITED 发明人 VOLLMERS, H. PETER
分类号 C07K16/44;A61K39/00;C07K16/18 主分类号 C07K16/44
代理机构 代理人
主权项
地址